Showing results (81-90 of 141) with videos related to
Sort By:
Pageof 15
Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2003
A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cellsSandip K Datta, Vanessa Redecke, Kiley R Prilliman, et al.Proceedings of the National Academy of Sciences of the United States of America|October 19, 2007
Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cellsKazumichi Abe, Kim Phung Nguyen, Sean D Fine, et al.Plos One|October 3, 2012
Treatment of autoimmune inflammation by a TLR7 ligand regulating the innate immune systemTomoko Hayashi, Shiyin Yao, Brian Crain, et al.Journal of Lipid Research|May 18, 2005
The role of natural antibodies in atherogenesisChristoph J Binder, Peter X Shaw, Mi-Kyung Chang, et al.Frontiers in Pain Research (Lausanne, Switzerland)|November 17, 2022
Macrophages and glial cells: Innate immune drivers of inflammatory arthritic pain perception from peripheral joints to the central nervous systemKaue Franco Malange, Juliana M Navia-Pelaez, Elayne Vieira Dias, et al.Frontiers in Pharmacology|January 4, 2021
Identification of Compounds With Glucocorticoid Sparing Effects on Suppression of Chemokine and Cytokine Production by Rheumatoid Arthritis Fibroblast-Like SynoviocytesTadashi Hosoya, Nikunj M Shukla, Yuya Fujita, et al.Nature Medicine|May 18, 2010
ERK activation drives intestinal tumorigenesis in Apc(min/+) miceSung Hee Lee, Li-Li Hu, Jose Gonzalez-Navajas, et al.Nature Communications|May 18, 2016
ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogationPetrus R de Jong, Koji Taniguchi, Alexandra R Harris, et al.The Journal of Clinical Investigation|January 7, 2010
TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in miceJosé M González-Navajas, Sean Fine, Jason Law, et al.Proceedings of the National Academy of Sciences of the United States of America|February 9, 2005
The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosisSiva Kumar Kolluri, Maripat Corr, Sharon Y James, et al.Pageof 15